Meeting Coverage

TCTM

"Viable" option for patients eligible for umbilical cord blood transplantation, investigator says

Durable responses with no unexpected or prolonged safety issues

April 27, 2022

1-year relapse-free survival rate of 60% with maintenance therapy after transplant

April 25, 2022

Conditioning with radiolabeled antibody leads to successful transplantation in 84% of older patients

February 25, 2020

Largest trial to date shows 73% ORR, 53% CR, potential for outpatient treatment

February 25, 2020

Similar PFS with haploidentical bone marrow, double unrelated umbilical cord blood

February 24, 2020

Targeting patients with high tumor burden reduced severe CRS by 50%

February 22, 2020

Better survival, fewer relapses compared with reduced-intensity conditioning

February 21, 2020

Longer survival after CR/CRi with CPX-351 than with 7+3 in patients with AML-MRC

February 21, 2020